维力医疗
(603309)
| 流通市值：35.78亿 | | | 总市值：35.91亿 |
| 流通股本：2.92亿 | | | 总股本：2.93亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 1,060,429,057.46 | 676,250,749.96 | 309,185,113.48 | 1,387,735,351.81 |
| 营业收入 | 1,060,429,057.46 | 676,250,749.96 | 309,185,113.48 | 1,387,735,351.81 |
| 二、营业总成本 | 874,790,564.58 | 551,484,535.72 | 248,108,389.65 | 1,158,743,225.7 |
| 营业成本 | 585,377,707.53 | 371,467,679.15 | 163,876,246.23 | 750,921,388.89 |
| 税金及附加 | 11,244,847.93 | 7,858,838.27 | 4,048,164.89 | 15,809,677.91 |
| 销售费用 | 108,203,581.92 | 66,406,839.51 | 29,847,787.18 | 158,426,580.39 |
| 管理费用 | 97,387,037.62 | 62,135,865.56 | 29,601,745.93 | 133,632,214.35 |
| 研发费用 | 66,811,813.9 | 43,125,049.46 | 20,475,295.9 | 94,921,846.1 |
| 财务费用 | 5,765,575.68 | 490,263.77 | 259,149.52 | 5,031,518.06 |
| 其中:利息费用 | 7,688,612.54 | 5,013,258.09 | 2,038,233.22 | 9,123,609.1 |
| 其中:利息收入 | 4,820,310.96 | 3,289,826.17 | 974,798.31 | 3,670,076.12 |
| 加:公允价值变动收益 | 171,547.83 | 863,236.91 | 433,118.74 | 76,156.88 |
| 加:投资收益 | 5,411,823.74 | 2,963,477.1 | 1,487,997.39 | 8,532,343.48 |
| 资产处置收益 | 67,434.79 | 12,275.4 | 12,275.42 | 94,625.48 |
| 资产减值损失(新) | 44,539.54 | -1,612,063.91 | -2,389,081.7 | -11,715,828.01 |
| 信用减值损失(新) | -28,490.69 | -442,884.11 | 436,642.37 | -39,109.76 |
| 其他收益 | 9,442,844.44 | 5,798,547.92 | 1,881,524.36 | 12,898,706.76 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 200,748,192.53 | 132,348,803.55 | 62,939,200.41 | 238,839,020.94 |
| 加:营业外收入 | 526,276.07 | 230,270.42 | 172,977.52 | 294,397.13 |
| 减:营业外支出 | 2,094,074.82 | 1,311,305.76 | 214,425.27 | 1,830,674.24 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 199,180,393.78 | 131,267,768.21 | 62,897,752.66 | 237,302,743.83 |
| 减:所得税费用 | 26,983,389.84 | 20,662,595.22 | 10,347,324.06 | 32,699,638.54 |
| 六、净利润 | 172,197,003.94 | 110,605,172.99 | 52,550,428.6 | 204,603,105.29 |
| 持续经营净利润 | 172,197,003.94 | 110,605,172.99 | 52,550,428.6 | 204,603,105.29 |
| 归属于母公司股东的净利润 | 166,726,371.77 | 106,053,566.29 | 50,255,959.75 | 192,485,118.47 |
| 少数股东损益 | 5,470,632.17 | 4,551,606.7 | 2,294,468.85 | 12,117,986.82 |
| (一)基本每股收益 | 0.57 | 0.36 | 0.17 | 0.66 |
| (二)稀释每股收益 | 0.57 | 0.36 | 0.17 | 0.66 |
| 八、其他综合收益 | - | - | - | -4,692,888.83 |
| 归属于母公司股东的其他综合收益 | - | - | - | -4,692,888.83 |
| 九、综合收益总额 | 172,197,003.94 | 110,605,172.99 | 52,550,428.6 | 199,910,216.46 |
| 归属于母公司股东的综合收益总额 | 166,726,371.77 | 106,053,566.29 | 50,255,959.75 | 187,792,229.64 |
| 归属于少数股东的综合收益总额 | 5,470,632.17 | 4,551,606.7 | 2,294,468.85 | 12,117,986.82 |
| 公告日期 | 2024-10-19 | 2024-07-26 | 2024-04-19 | 2024-04-19 |
| 审计意见(境内) | | | | 标准无保留意见 |